Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
51.53
+0.02 (0.04%)
At close: Nov 20, 2024, 4:00 PM
51.80
+0.27 (0.52%)
Pre-market: Nov 21, 2024, 5:41 AM EST
Viking Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 42.81 | 37.02 | 16.12 | 10.7 | 10.73 | 9.13 | |
| Research & Development | 91.16 | 63.81 | 54.23 | 44.98 | 31.93 | 23.56 | |
| Operating Expenses | 133.97 | 100.83 | 70.36 | 55.68 | 42.66 | 32.69 | |
| Operating Income | -133.97 | -100.83 | -70.36 | -55.68 | -42.66 | -32.69 | |
| Interest Expense | -0.1 | -0.09 | -0.06 | -0.02 | -0.11 | -0.15 | |
| Interest & Investment Income | 34.8 | 15.02 | 1.59 | 0.7 | 3.23 | 7.05 | |
| Currency Exchange Gain (Loss) | - | - | - | 0.01 | - | - | |
| EBT Excluding Unusual Items | -99.26 | -85.9 | -68.83 | -54.99 | -39.54 | -25.78 | |
| Gain (Loss) on Sale of Investments | 0.11 | - | -0.04 | - | 0.04 | 0 | |
| Pretax Income | -99.15 | -85.9 | -68.87 | -54.99 | -39.5 | -25.78 | |
| Net Income | -99.15 | -85.9 | -68.87 | -54.99 | -39.5 | -25.78 | |
| Net Income to Common | -99.15 | -85.9 | -68.87 | -54.99 | -39.5 | -25.78 | |
| Shares Outstanding (Basic) | 106 | 94 | 77 | 77 | 73 | 72 | |
| Shares Outstanding (Diluted) | 106 | 94 | 77 | 77 | 73 | 72 | |
| Shares Change (YoY) | 19.97% | 22.79% | -0.47% | 6.34% | 0.89% | 24.97% | |
| EPS (Basic) | -0.93 | -0.91 | -0.90 | -0.71 | -0.54 | -0.36 | |
| EPS (Diluted) | -0.93 | -0.91 | -0.90 | -0.71 | -0.54 | -0.36 | |
| Free Cash Flow | -74.25 | -73.38 | -48.4 | -47.59 | -21.78 | -24.75 | |
| Free Cash Flow Per Share | -0.70 | -0.78 | -0.63 | -0.62 | -0.30 | -0.34 | |
| EBIT | -133.97 | -100.83 | -70.36 | -55.68 | -42.66 | -32.69 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.